SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Synergistic augmentation of rhythmic myogenic contractions of human stomach by arginine vasopressin and adrenaline: Implications for the induction of nausea.

Makwana, R; Crawley, E; Straface, M; Palmer, A; Gharibans, A; Devalia, K; Loy, J; O'Grady, G; Andrews, PLR; Sanger, GJ (2022) Synergistic augmentation of rhythmic myogenic contractions of human stomach by arginine vasopressin and adrenaline: Implications for the induction of nausea. Br J Pharmacol, 179 (24). pp. 5305-5322. ISSN 1476-5381 https://doi.org/10.1111/bph.15943
SGUL Authors: Andrews, Paul Lyn Rodney

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview
[img]
Preview
PDF (Supplementary figures) Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[img] Microsoft Word (.docx) (Supporting information) Published Version
Available under License Creative Commons Attribution.

Download (44kB)
[img] Microsoft Word (.docx) (Supplementary tables) Published Version
Available under License Creative Commons Attribution.

Download (65kB)
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview

Abstract

BACKGROUND AND PURPOSE: Nausea is associated with the hormonal secretion of vasopressin and adrenaline, although their actions in inducing nausea is poorly understood. Here, we have investigated their actions on human stomach muscle. EXPERIMENTAL APPROACH: Muscle strips were suspended in tissue baths and neuronal-/non-neuronally-mediated contractions were measured. Custom software analysed eight motility parameters defining spontaneous phasic non-neuronally mediated contractions. Receptor distributions were assessed by qPCR and immunofluorescence. KEY RESULTS: V1A receptors and α1 -adrenoceptors were located on muscle as well as interstitial cells of Cajal (ICCs). Myogenic contractions of human proximal and distal stomach (respectively, 2.6 ± 0.1 and 2.7 ± 0.0 per minute; n = 44) were larger in the distal area (1.1 ± 0.1 and 5.0 ± 0.1 mN), developing relatively slowly (proximal) or rapidly (distal). Vasopressin caused tonic (proximal) or short-lived (distal) increases in muscle tone and increased myogenic contraction amplitude, frequency and rate (acting at V1A receptors; thresholds 10-11 -10-10  M); by contrast, cholinergically mediated contractions were unaffected. Oxytocin acted similarly to vasopressin but less potently, at OT receptors). Adrenaline increased (10-10 -10-5  M; α1 -adrenoceptors) and decreased (≥10-6  M; β-adrenoceptors) muscle tone and enhanced/reduced myogenic contractions. Cholinergically mediated contractions were reduced (α2 -adrenoceptors). Combined, vasopressin (10-9  M) and adrenaline (10-8  M) increased muscle tone and phasic myogenic activity in a synergistic manner. CONCLUSIONS AND IMPLICATIONS: Vasopressin and adrenaline increased human gastric tone and myogenic contraction amplitude, rate of contraction and frequency. In combination, their actions were further increased in a synergistic manner. Such activity may promote nausea.

Item Type: Article
Additional Information: © 2022 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: adrenaline, arginine vasopressin, human, interstitial cells of Cajal, nausea, stomach, arginine vasopressin, adrenaline, human, interstitial cells of Cajal, nausea, stomach, [Arg8]-vasopressin, Adrenaline, Human, Interstitial cells of Cajal, Nausea, Stomach, 1115 Pharmacology and Pharmaceutical Sciences, Pharmacology & Pharmacy
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Br J Pharmacol
ISSN: 1476-5381
Language: eng
Dates:
DateEvent
9 November 2022Published
22 September 2022Published Online
2 September 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDTakeda Pharmaceuticals North AmericaUNSPECIFIED
PubMed ID: 36068676
Web of Science ID: WOS:000856587600001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114847
Publisher's version: https://doi.org/10.1111/bph.15943

Actions (login required)

Edit Item Edit Item